MG
LIVN icon

Michael Gelband’s LivaNova LIVN Stock Holding History

Michael Gelband’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$3.31M – 2382
2020
Q4 		$3.31M Buy
+50,000
New +$2.78M 0.03% 365

Other funds holding LIVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Michael Gelband's LIVN Position: Q2 2026 in Review

Michael Gelband reduced its LivaNova (LIVN) stake by 58% in Q2 2026, selling an estimated $20.4M and leaving 207,801 shares worth $17.1M. The position accounts for 0.11% of the portfolio, ranked #163.

Michael Gelband first reported a position in LIVN in Q3 2019 and has held it in 19 quarters since. The position peaked at $39M in Q1 2025. 301 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.

  • Michael Gelband held 207,801 shares of LivaNova worth $17.1M as of Q2 2026.
  • Michael Gelband sold 287,817 LivaNova shares in Q2 2026, an estimated $20.4M.
  • LivaNova made up 0.11% of Michael Gelband's portfolio in Q2 2026, its #163 holding.
  • Michael Gelband first reported a position in LivaNova in Q3 2019 and has held it in 19 quarters since.
  • Michael Gelband's LivaNova position peaked at $39M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.